Alex Wolff


Alex Wolff is a Partner at DPE Oil Venture and focuses on the creation, development and business strategy of novel therapeutics companies. He is a founder and the chairman, and previously acting CEO, of Horizon Bio, and a founder, the chairman and a member of the board of directors of CRC. Prior to joining DPE in 2014, Jason was a partner of Epizyme, Inc. (NASDAQ: EPZM), a public biopharmaceutical company. Prior to Epizyme, Jason led business development at Novel. He holds a BA from Havard University and Masters from the London School of Business